Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.2237
-0.0053 (-2.31%)
Jun 27, 2025, 4:00 PM - Market closed
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $7.51 million as of June 27, 2025. Its market cap has decreased by -56.64% in one year.
Market Cap
7.51M
Enterprise Value
1.66M
1-Year Change
-56.64%
Ranking
Category
Stock Price
$0.22
Market Cap Chart
Since November 1, 2021, Calidi Biotherapeutics's market cap has decreased from $273.84M to $7.51M, a decrease of -97.26%. That is a compound annual growth rate of -62.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 7.51M | -66.17% |
| Dec 31, 2024 | 22.21M | -58.52% |
| Dec 29, 2023 | 53.55M | -46.69% |
| Dec 30, 2022 | 100.46M | -64.38% |
| Dec 30, 2021 | 282.04M | 2.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 704.27B |
| Johnson & Johnson | 367.48B |
| AbbVie | 329.08B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 279.40B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 233.28B |
| AstraZeneca | 215.99B |